Author:
Van Binsbergen JJ,Verhoeven S,Van Bentum STB,Schuling J,Beusmans GHMI,Pleumeekers HJCM,Wiersma Tj
Reference110 articles.
1. Adams HP Jr, Kassell NF, Mazuz H. The patient with transient ischemic attacks. Is this the time for a new therapeutic approach? Stroke 1984;15:371–375.
2. Ad hoc committee on cerebrovascular diseases. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990;21:637–636.
3. Alamowitch S, Eliasziw M, Algra A, Meldrum H, Barnett HJ for the North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet 2001;357:1154–1160.
4. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, et al. Transient ischemic attack. Proposal for a new definition. N Engl J Med 2002;347:1713–1716.
5. Algra A. 30 mg acetylsalicylzuur per dag even effectief als 283 mg bij patiënten na een ‘transient ischaemic attack’ of een niet-invaliderend herseninfarct, en met minder bijwerkingen. Ned Tijdschr Geneeskd 1991;135:2273–2280.